LM11A-31

N/A

Report date: 2026/04/28 20:00:22
NME

Base Information

Drug NameLM11A-31
Drug Alias NameLM11A-31-BHSLM11A-31
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionLow affinity neurotrophin receptor p75NTR modulators
TargetsLow affinity neurotrophin receptor p75NTR
Therapy Area/IndicationsAlzheimer DiseaseSupranuclear Palsy, Progressive
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechiaSwedenAustria +[5] 
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesPharmatrophix Inc
China Registration ClassN/A

Develop Information

Active CompaniesPharmatrophix Inc
Inactive CompaniesN/A
Active IndicationsSupranuclear Palsy, Progressive
Inactive IndicationsAlzheimer Disease

Other Information

ATC CodeN/A
Related LinksN/A